Positive iron balance in chronic kidney disease: how much is too much and how to tell?
JB Wish, GR Aronoff, BR Bacon, C Brugnara… - American journal of …, 2018 - karger.com
Background: Regulation of body iron occurs at cellular, tissue, and systemic levels. In
healthy individuals, iron absorption and losses are minimal, creating a virtually closed …
healthy individuals, iron absorption and losses are minimal, creating a virtually closed …
Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD and IBD populations
G Rostoker, ND Vaziri - Heliyon, 2019 - cell.com
The routine use of recombinant erythropoiesis-stimulating agents (ESA) over the past three
decades has enabled the partial correction of anaemia in most patients with end-stage renal …
decades has enabled the partial correction of anaemia in most patients with end-stage renal …
[PDF][PDF] Risk of iron overload with chronic indiscriminate use of intravenous iron products in ESRD
G Rostoker, ND Vaziri - Heliyon, 5 (7), 2019 - academia.edu
The routine use of recombinant erythropoiesis-stimulating agents (ESA) over the past three
decades has enabled the partial correction of anaemia in most patients with end-stage renal …
decades has enabled the partial correction of anaemia in most patients with end-stage renal …
[引用][C] HFE gene mutations are not risk factors for iron overload in European hemodialysis patients
G Rostoker, M Griuncelli, Y Cohen - Hemodialysis International, 2017 - Wiley Online Library
To the Editor: Turkmen et al. 1 assessed 36 Turkish hemodialysis patients using hepatic and
cardiac T2* magneticresonance imaging (MRI) to determine if HFE gene mutations were …
cardiac T2* magneticresonance imaging (MRI) to determine if HFE gene mutations were …